Urogen Pharma Ltd
NASDAQ:URGN

Watchlist Manager
Urogen Pharma Ltd Logo
Urogen Pharma Ltd
NASDAQ:URGN
Watchlist
Price: 10.45 USD -1.79%
Market Cap: 441m USD
Have any thoughts about
Urogen Pharma Ltd?
Write Note

Intrinsic Value

The intrinsic value of one URGN stock under the Base Case scenario is 30.4 USD. Compared to the current market price of 10.45 USD, Urogen Pharma Ltd is Undervalued by 66%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

URGN Intrinsic Value
30.4 USD
Undervaluation 66%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Urogen Pharma Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
URGN
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for URGN cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about URGN?
Bearish
Neutral
Bullish

Fundamental Analysis

10.45 USD
-1.79%
-1.79%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Urogen Pharma Ltd
IL
Biotechnology
Market Cap
440.9m USD
IPO
May 4, 2017
Employees
195
Israel
Market Cap
440.9m USD
Industry
Biotechnology
IPO
May 4, 2017
Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Urogen Pharma Ltd

Provide an overview of the primary business activities
of Urogen Pharma Ltd.

What unique competitive advantages
does Urogen Pharma Ltd hold over its rivals?

What risks and challenges
does Urogen Pharma Ltd face in the near future?

Has there been any significant insider trading activity
in Urogen Pharma Ltd recently?

Summarize the latest earnings call
of Urogen Pharma Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Urogen Pharma Ltd.

Provide P/S
for Urogen Pharma Ltd.

Provide P/E
for Urogen Pharma Ltd.

Provide P/OCF
for Urogen Pharma Ltd.

Provide P/FCFE
for Urogen Pharma Ltd.

Provide P/B
for Urogen Pharma Ltd.

Provide EV/S
for Urogen Pharma Ltd.

Provide EV/GP
for Urogen Pharma Ltd.

Provide EV/EBITDA
for Urogen Pharma Ltd.

Provide EV/EBIT
for Urogen Pharma Ltd.

Provide EV/OCF
for Urogen Pharma Ltd.

Provide EV/FCFF
for Urogen Pharma Ltd.

Provide EV/IC
for Urogen Pharma Ltd.

Show me price targets
for Urogen Pharma Ltd made by professional analysts.

What are the Revenue projections
for Urogen Pharma Ltd?

How accurate were the past Revenue estimates
for Urogen Pharma Ltd?

What are the Net Income projections
for Urogen Pharma Ltd?

How accurate were the past Net Income estimates
for Urogen Pharma Ltd?

What are the EPS projections
for Urogen Pharma Ltd?

How accurate were the past EPS estimates
for Urogen Pharma Ltd?

What are the EBIT projections
for Urogen Pharma Ltd?

How accurate were the past EBIT estimates
for Urogen Pharma Ltd?

Compare the revenue forecasts
for Urogen Pharma Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Urogen Pharma Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Urogen Pharma Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Urogen Pharma Ltd compared to its peers.

Compare the P/E ratios
of Urogen Pharma Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Urogen Pharma Ltd with its peers.

Analyze the financial leverage
of Urogen Pharma Ltd compared to its main competitors.

Show all profitability ratios
for Urogen Pharma Ltd.

Provide ROE
for Urogen Pharma Ltd.

Provide ROA
for Urogen Pharma Ltd.

Provide ROIC
for Urogen Pharma Ltd.

Provide ROCE
for Urogen Pharma Ltd.

Provide Gross Margin
for Urogen Pharma Ltd.

Provide Operating Margin
for Urogen Pharma Ltd.

Provide Net Margin
for Urogen Pharma Ltd.

Provide FCF Margin
for Urogen Pharma Ltd.

Show all solvency ratios
for Urogen Pharma Ltd.

Provide D/E Ratio
for Urogen Pharma Ltd.

Provide D/A Ratio
for Urogen Pharma Ltd.

Provide Interest Coverage Ratio
for Urogen Pharma Ltd.

Provide Altman Z-Score Ratio
for Urogen Pharma Ltd.

Provide Quick Ratio
for Urogen Pharma Ltd.

Provide Current Ratio
for Urogen Pharma Ltd.

Provide Cash Ratio
for Urogen Pharma Ltd.

What is the historical Revenue growth
over the last 5 years for Urogen Pharma Ltd?

What is the historical Net Income growth
over the last 5 years for Urogen Pharma Ltd?

What is the current Free Cash Flow
of Urogen Pharma Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Urogen Pharma Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Urogen Pharma Ltd

Current Assets 295.1m
Cash & Short-Term Investments 249.6m
Receivables 22.8m
Other Current Assets 22.7m
Non-Current Assets 6.8m
Long-Term Investments 4.6m
PP&E 1.7m
Other Non-Current Assets 545k
Current Liabilities 32.8m
Accounts Payable 5.6m
Accrued Liabilities 24m
Other Current Liabilities 3.2m
Non-Current Liabilities 243.6m
Long-Term Debt 121.7m
Other Non-Current Liabilities 121.9m
Efficiency

Earnings Waterfall
Urogen Pharma Ltd

Revenue
89.4m USD
Cost of Revenue
-8.7m USD
Gross Profit
80.7m USD
Operating Expenses
-164.4m USD
Operating Income
-83.7m USD
Other Expenses
-31.6m USD
Net Income
-115.4m USD

Free Cash Flow Analysis
Urogen Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

URGN Profitability Score
Profitability Due Diligence

Urogen Pharma Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROE
Positive Gross Profit
Exceptional Revenue Growth Forecast
Exceptional ROE
53/100
Profitability
Score

Urogen Pharma Ltd's profitability score is 53/100. The higher the profitability score, the more profitable the company is.

URGN Solvency Score
Solvency Due Diligence

Urogen Pharma Ltd's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Long-Term Solvency
High D/E
44/100
Solvency
Score

Urogen Pharma Ltd's solvency score is 44/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

URGN Price Targets Summary
Urogen Pharma Ltd

Wall Street analysts forecast URGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for URGN is 40.73 USD with a low forecast of 22.22 USD and a high forecast of 67.2 USD.

Lowest
Price Target
22.22 USD
113% Upside
Average
Price Target
40.73 USD
290% Upside
Highest
Price Target
67.2 USD
543% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for URGN?

Click here to dive deeper.

Dividends

Urogen Pharma Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for URGN is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

URGN Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

See Also

Discover More
What is the Intrinsic Value of one URGN stock?

The intrinsic value of one URGN stock under the Base Case scenario is 30.4 USD.

Is URGN stock undervalued or overvalued?

Compared to the current market price of 10.45 USD, Urogen Pharma Ltd is Undervalued by 66%.

Back to Top